These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 3160389

  • 1. Photoaffinity labeling of functionally different lysine-binding sites in human plasminogen and plasmin.
    Ryan TJ, Keegan MC.
    Biochim Biophys Acta; 1985 Aug 08; 830(2):187-94. PubMed ID: 3160389
    [Abstract] [Full Text] [Related]

  • 2. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB, Gaĭsarian ES, Snitko IaE, Varfolomeev SD.
    Bioorg Khim; 1994 Feb 08; 20(2):182-9. PubMed ID: 8155080
    [Abstract] [Full Text] [Related]

  • 3. Plasmin: photoaffinity labeling of a lysine-binding site which regulated clot lysis.
    Ryan TJ.
    Biochem Biophys Res Commun; 1981 Feb 27; 98(4):1108-14. PubMed ID: 6452880
    [No Abstract] [Full Text] [Related]

  • 4. The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.
    Lucas MA, Straight DL, Fretto LJ, McKee PA.
    J Biol Chem; 1983 Oct 25; 258(20):12171-7. PubMed ID: 6226655
    [Abstract] [Full Text] [Related]

  • 5. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
    Sugiyama N, Iwamoto M, Abiko Y.
    Thromb Res; 1987 Aug 15; 47(4):459-68. PubMed ID: 2821651
    [Abstract] [Full Text] [Related]

  • 6. Skizzle is a novel plasminogen- and plasmin-binding protein from Streptococcus agalactiae that targets proteins of human fibrinolysis to promote plasmin generation.
    Wiles KG, Panizzi P, Kroh HK, Bock PE.
    J Biol Chem; 2010 Jul 02; 285(27):21153-64. PubMed ID: 20435890
    [Abstract] [Full Text] [Related]

  • 7. Isolation of a human plasmin-derived, functionally active, light (B) chain capable of forming with streptokinase an equimolar light (B) chain-streptokinase complex with plasminogen activator activity.
    Summaria L, Robbins KC.
    J Biol Chem; 1976 Sep 25; 251(18):5810-13. PubMed ID: 134997
    [Abstract] [Full Text] [Related]

  • 8. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.
    Bok RA, Mangel WF.
    Biochemistry; 1985 Jun 18; 24(13):3279-86. PubMed ID: 3161540
    [Abstract] [Full Text] [Related]

  • 9. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
    Pannell R, Black J, Gurewich V.
    J Clin Invest; 1988 Mar 18; 81(3):853-9. PubMed ID: 2963831
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the esterase and human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes.
    Wohl RC, Arzadon L, Summaria L, Robbins KC.
    J Biol Chem; 1977 Feb 25; 252(4):1141-7. PubMed ID: 851483
    [Abstract] [Full Text] [Related]

  • 11. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E, Thorsen S.
    Biochem J; 1981 Sep 01; 197(3):619-28. PubMed ID: 6459779
    [Abstract] [Full Text] [Related]

  • 12. Streptokinase binds preferentially to the extended conformation of plasminogen through lysine binding site and catalytic domain interactions.
    Boxrud PD, Bock PE.
    Biochemistry; 2000 Nov 14; 39(45):13974-81. PubMed ID: 11076540
    [Abstract] [Full Text] [Related]

  • 13. Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin I.
    Harpel PC, Chang TS, Verderber E.
    J Biol Chem; 1985 Apr 10; 260(7):4432-40. PubMed ID: 3156857
    [Abstract] [Full Text] [Related]

  • 14. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
    Anonick PK, Vasudevan J, Gonias SL.
    Arterioscler Thromb; 1992 Jun 10; 12(6):708-16. PubMed ID: 1375508
    [Abstract] [Full Text] [Related]

  • 15. Epsilon amino caproic acid inhibits streptokinase-plasminogen activator complex formation and substrate binding through kringle-dependent mechanisms.
    Lin LF, Houng A, Reed GL.
    Biochemistry; 2000 Apr 25; 39(16):4740-5. PubMed ID: 10769130
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of action of fibrinolytic enzymes in vivo.
    Ambrus JL, Weber FJ, Ambrus CM.
    J Med; 1979 Apr 25; 10(1-2):99-119. PubMed ID: 158624
    [Abstract] [Full Text] [Related]

  • 17. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.
    Suenson E, Lützen O, Thorsen S.
    Eur J Biochem; 1984 May 02; 140(3):513-22. PubMed ID: 6233145
    [Abstract] [Full Text] [Related]

  • 18. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
    Urano S, Metzger AR, Castellino FJ.
    Proc Natl Acad Sci U S A; 1989 Apr 02; 86(8):2568-71. PubMed ID: 2523073
    [Abstract] [Full Text] [Related]

  • 19. Thrombospondin is a slow tight-binding inhibitor of plasmin.
    Hogg PJ, Stenflo J, Mosher DF.
    Biochemistry; 1992 Jan 14; 31(1):265-9. PubMed ID: 1531022
    [Abstract] [Full Text] [Related]

  • 20. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B, Rojas G, Vranckx R, Lijnen HR, Anglés-Cano E.
    FEBS J; 2005 Jul 14; 272(13):3387-400. PubMed ID: 15978044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.